#TRLInsights - According to Tufts CSDD, the number of biotech products in late-stage clinical trials has quadrupled during the p
06 Nov 2023, 12:05
#TRLInsights - According to Tufts CSDD, the number of biotech products in late-stage clinical trials has quadrupled during the past decade.
594 novel #biotech products, 146 marketed products, and 192 #biosimilars are currently in Phase 3 studies.
Source: